Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-12-4
pubmed:abstractText
HBV DNA and HCV RNA viremia levels may fluctuate over time in HBV-HCV-coinfected patients. Long-term follow-up data of more than 6 months after PEG-IFNa + ribavirin treatment of HBV/HCV co-infection are lacking. We here report that HBV may reactivate, even after a period of years, in HBV- and HCV-co-infected patients if HCV is cleared by antiviral therapy. In contrast, a sustained response concerning HCV is durable. We recommend long-term monitoring of HBV/HCV-co-infected patients after IFN a-based therapies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1502-7708
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1487-90
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
pubmed:affiliation
Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany.
pubmed:publicationType
Journal Article, Clinical Trial